Cw-100 Stirring Double Cone Mixing Machine

Name: Cw-100 Stirring Double Cone Mixing Machine
Brand: Shanghai Pharmaceutical Machinery Co., Ltd.
SKU: 771812785

Shanghai, ChinaShanghai Pharmaceutical Machinery Co., Ltd.

US$1.00-5,000.00

1 Set

Product profile

Additional Capabilities

Milling

Application

Powder, Granules

Application Area

Pharmaceutical

Model NO.

Cw-100

Certification

CE, ISO, GOST, SONCAP, CCC

Condition

New

Stirring Type

Spiral

Working

Shear Mixer

Barrel Volume(L)

100

Mixing Motor

1.5

Stirring Motor

1.1

Mixing Rotary Speed (Rpm/Min)

Stirring Rotary Speed(Rpm/Min)

Mixer Type

Double Screw Cone Mixer

Layout Type

Horizontal

Mixing Drum Shape

Double Cone

Operating type

Cycle Operating

Transport Package

Seaworthy

Specification

GMP

Trademark

SPM

Origin

Shanghai

HS Code

8474390000

Production Capacity

100L/Load

Company profile

Experienced TeamExhibition ExperienceImporters and ExportersLow MOQ

Shanghai Pharmaceutical Machinery Co., Ltd.

Shanghai, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤7.00h CertifiedTerms of Payment: T/T, LC, PayPal, etc.

AI-Powered supplier vetting

SummaryThe supplier is identified as a Shanghai-based combined trading company with listed pharmaceutical equipment products and machining-related facilities. It reports extensive customization, R&D activity with new products in the past year, export experience of 20 years, and exports representing 90% of total sales. After-sales support includes repair services and overseas agents or branches, but no overseas warehouse or showroom. Finished-product inspection instructions are reportedly available and uniformly followed. The supplier does not provide ODM services, lacks an available SDK, and does not provide OEM services for well-known brands. Evidence is insufficient to verify certifications, detailed financial credibility, production scale, or named customer cases.

After-Sales capabilityThe supplier reports repair as an overseas service offering and states that it can provide services through overseas agents or branches. However, it has no overseas warehouse or showroom, so the evidence supports some service access but not comprehensive overseas infrastructure.

R&D capabilityThe supplier reports R&D capability and states that it launched new products during the past year. It does not have an available SDK and does not provide ODM services, but these limitations do not negate the explicit evidence of recent product development.

Production capacityThe supplier lists machining centers, CNC and milling equipment, provides a broad pharmaceutical-equipment product range, and reports a finished-product inspection method with instructions that are uniformly followed. However, the supplied data does not quantify production capacity, output, or manufacturing ownership, so production strength is only partially evidenced.

Customization capabilityBoth R&D and design-service records explicitly list customization from samples, designs, full customization, minor customization, and flexible customization. This is direct evidence of a broad customization offering.